Over the past decade, acute kidney injury (AKI) has emerged rapidly in the scientific literature and clinical awareness. There have been great strides in understanding the pathophysiology and adverse outcomes associated with AKI. In this special issue on acute kidney injury (AKI), contributing authors discuss novel clinical and experimental research emerging in the field of AKI. Several experiments focused on the issue of renal ischemia-reperfusion injury in animal models. E. C. Costalonga et al. examined whether valproic acid could prevent renal ischemia-reperfusion injury and subsequent AKI in male Wistar rats. S. Ozbilgin et al. explored whether ischemic preconditioning could prevent reperfusion injury in diabetic rats. Lastly, D. Wen et al. in an in vivo model discuss the role of a DNA binding 1 inhibitor during renal ischemia-reperfusion injury.
Review of the Literature. Two reviews provide a critical appraisal of the literature on the role of cisplatin nephrotoxicity and a technology evaluation on the role of renal magnetic resonance imaging in patients with AKI. G. Oh et al. provide a review on cisplatin nephrotoxicity operating through oxidative stress and inflammation and by the reduction of the intracellular NAD + /NADH ratio. 
